Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis A Gimotty

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Gastroenterology|April 29, 2015
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaAaron J Small, James L Araujo, Cadman L Leggett, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
JCI Insight|August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Nature Cell Biology|February 16, 2023
Stiff matrix induces exosome secretion to promote tumour growthBin Wu, Di-Ao Liu, Lei Guan, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Cancer Cell|December 16, 2010
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3KJessie Villanueva, Adina Vultur, John T Lee, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
International Journal of Cancer|June 2, 2020
Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived modelsNicole D Facompre, Pavithra Rajagopalan, Varun Sahu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid TumorsClinton Yam, Xiaowei Xu, Michael A Davies, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Gastroenterology|April 29, 2015
Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaAaron J Small, James L Araujo, Cadman L Leggett, et al.
JCI Insight|July 23, 2016
A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemiaMarlise R Luskin, Phyllis A Gimotty, Catherine Smith, et al.
JCI Insight|August 12, 2020
PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanomaGaurav Sharma, Rani Ojha, Estela Noguera-Ortega, et al.
JAMA Internal Medicine|October 1, 2020
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical TrialBenjamin S Abella, Eliana L Jolkovsky, Barbara T Biney, et al.
Nature Cell Biology|February 16, 2023
Stiff matrix induces exosome secretion to promote tumour growthBin Wu, Di-Ao Liu, Lei Guan, et al.
Annals of Surgical Oncology|November 14, 2018
Microsatellitosis in Patients with MelanomaGiorgos C Karakousis, Phyllis A Gimotty, Stanley P Leong, et al.
Cancer Cell|December 16, 2010
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3KJessie Villanueva, Adina Vultur, John T Lee, et al.
Blood Advances|January 31, 2025
Evolving racial/ethnic disparities in AML survival in the novel therapy eraXin Wang, Phyllis A Gimotty, Andrew H Matthews, et al.
International Journal of Cancer|June 2, 2020
Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived modelsNicole D Facompre, Pavithra Rajagopalan, Varun Sahu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2017
A Multicenter Phase I Study Evaluating Dual PI3K and BRAF Inhibition with PX-866 and Vemurafenib in Patients with Advanced BRAF V600-Mutant Solid TumorsClinton Yam, Xiaowei Xu, Michael A Davies, et al.
Pageof 15